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Abstract
Alamethicin is known to lyse different biological cells and to induce voltage dependent ion channels in lipid bilayers. A
set of analogs with proline shifted from position 14 in the native peptide towards the N- and C-terminus was used to
 .  .investigate the role of proline in: i alamethicin induced hemolysis of human red blood cells, ii stimulation of
 .catecholamine secretion from bovine adrenal chromaffin cells and iii induction of metabolic activity in bovine aortic
endothelial cells. Half maximal hemolytic activity was found at 30 mM alamethicin concentration, complete lysis occurred
at 100 mM. The stimulation of catecholamine secretion in the presence of extracellular Ca2q was concentration dependent
up to 50 mM alamethicin. At this high concentration mild secretion was also found in the absence of Ca2q indicating cell
membrane damage. Alamethicin transiently stimulated the metabolic rate of endothelial cells in a concentration dependent
mode up to 20 mM while the inhibition of metabolism at higher concentrations pointed to a toxic effect. The alamethicin
analogs were completely inactive in all the biological assays. The effects correlated with a loss of dye release inducing
activities on phosphatidylcholine vesicles and reduction of channel forming properties in lipid bilayers and were associated
with modifications of membrane affinity rather than conformational changes of the peptides. The results indicate that
proline at position 14 of the native peptide is essential for the interaction with different membrane systems. q 1998 Elsevier
Science B.V.
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1. Introduction
Trichoderma are widespread soil fungi character-
ized by the production of cytolytic enzymes and
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antibiotic peptides. The peptides exhibit a broad spec-
trum of bio-activity, including growth inhibition of
w xGram positive bacteria induced by alamethicin 1,2
w xand saturnisporins 3 and inhibition of amoebae cell
w xmultiplication by trichorzianines 4 . Hemolysis
w x w xcaused by alamethicin 5 and paracelsin 6 , lysis of
leukocytes exposed to alamethicin, suzukacillin and
0005-2736r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved.
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w xtrichotoxin 7,8 , catecholamine release from adrenal
w xchomaffin cells stimulated by trichosporins 9,10 and
w xtrichorcellins 11 and uncoupling of oxidative phos-
phorylation in mitochondria caused by alamethicin
w x w x12 and trichosporins 13 are examples of their
actions on mammalian cells. These effects have all
been related to a reduction of the barrier function of
the cell membranes. Voltage induced ion conductance
w xin lipid bilayers by alamethicin 14,15 , trichorzianins
w x w x w x16 , trichosporins 9 and trichocellins 11 and the
release of dye entrapped in lipid vesicles in the
w x w xpresence of trichorzianins 4 , saturnisporins 3 and
w xharzianin 17 have been observed in model mem-
brane systems, confirming the membrane permeabi-
lizing activity of the peptides.
Numerous papers have tried to rationalize the rela-
tionship between the structure of the peptaibols with
their ion-channel forming ability in bilayers or their
capability to disorder the lipid matrix of membranes
w x9,16,18–20 .
Alamethicin, originally isolated from the fungus
Trichoderma ˝iride is one of the best characterized
peptaibols. It is a linear peptide consisting of 20
amino acid residues with an acetylated N-terminus
and an aminoalcohol at the C-terminus. In common
with the other peptaibols, alamethicin contains highly
hydrophobic residues with a high proportion of the
helicogenic a-methylalanine and a proline at position
14 inducing a kink in the largely helical arrangement
of the peptide chain and conferring flexibility to the
C-terminal half. The resulting amphipathic bent-rod
structure, highly hydrophobic in the N-terminus and
rich in polar residues at the C-terminus has been
suggested to play a decisive role in the function of
the peptaibol. Thus, using an alamethicin analog
w xDuclohier et al. 21 showed that the substitution of
proline 14 by alanine did not prevent voltage induced
conductivity in lipid bilayers but distinctly reduced
single channel formation. Also proline 14 substitution
in trichosporin-Bs by a- methylalanine did not alter
the voltage activation of ion channels but seriously
reduced the probability of channel formation, the
w xnumber of levels and their open times 20 .
w xIn our recent studies 22 , alamethicin peptides
with proline in positions different to 14 were found to
display reduced conductivity inducing properties. Al-
though voltage dependent macroscopic current flow
remained detectable, single channel events were found
only for analogs with proline at positions 15, 16 or 13
while further shifts towards the N- and C-terminus
abolished channel formation.
This paper describes the effect of the change of
proline 14 position in alamethicin on biological activ-
ities such as lysis of human red blood cells and
catecholamine secretion from bovine adrenal chro-
maffin cells. In addition, a novel approach, namely
determination of changes of the metabolic rate of
bovine endothelial cells has been used to obtain
further information concerning alamethicin
peptidesrmammalian cell membrane interactions.
Peptide induced permeabilization of model mem-
branes was studied by monitoring the dye release
from phosphatidylglycerol liposomes. The biological
effects have been related to the channel forming
properties of the peptides and their lytic effect on
lipid vesicles to contribute to an understanding of the
general mechanistic principles of the membrane ac-
tivity of alamethicin.
2. Materials and methods
2.1. Peptide synthesis
Alamethicin F 30 and the analogs were synthesised
by means of Fmoc amino acid fluorides using the
w xmultiple peptide synthesis technique 23 . Fmoc amino
acid fluorides were prepared according to the proce-
w xdure described recently 24 . All peptides were ana-
lyzed using reversed-phase high performance liquid
 .chromatography HPLC and electrospray ionization
mass spectrometry. The peptide content was deter-
mined by quantitative amino acid analysis. Table 1
summarizes the sequences used.
2.2. Hemolytic acti˝ity
The hemolytic activity of the peptides was deter-
mined using human red blood cells as described
w xpreviously 25 . In brief, 150 ml of cell suspension
containing 1.2=109 cellsrml and varying amounts
wof peptide stock solution concentration usually
y4 x10 molrl in Tris buffer and buffer were pipetted
into Eppendorf tubes to give a final volume of 1 ml.
The suspensions containing 1.8=108 cellsrml were
incubated for 30 min at 378C. After cooling in ice
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a Aib denotes a- methylalanine.
water and centrifugation at 2000=g for 5 min 200 ml
of supernatant was combined with 1.8 ml of 0.5%
NH OH and the optical density was measured at4
540 nm. Peptide concentrations causing 50% hemoly-
w xsis EC were derived from the dose-response50
curves.
2.3. Catecholamine secretion from chromaffin cells
Bovine adrenal chromaffin cells were isolated by
w xcollagenase digestion as described elsewhere 26 .
After four days of culturing in Eagle’s minimum
 6essential medium, the chromaffin cells 2=10
.cellsrdish were washed twice with Krebs-Ringer-
 .Hepes-buffer KRH and pre-incubated in KRH solu-
tion at 378C for 10 min. After washing again, the
cells were incubated with or without the alamethicin
peptides at 378C for 7 min. The reaction was termi-
nated by transferring the incubation medium to tubes
in ice-cold water. The catecholamines secreted into
the medium were extracted with 0.4 M perchloric
acid, adsorbed on aluminium hydroxide and quanti-
fied by the ethylenediamine condensation method
using a fluorescence spectrometer 650-10S, Hitachi,
.Tokyo, Japan at an excitation wavelength of 420 nm
w xand an emission wavelength of 540 nm 27 . The
amount of secreted catecholamines was expressed as
percentage of the total cellular catecholamines. A
Ca2q free medium was prepared by omitting Ca2q
wand adding 0.2 mM ethylene glycero bis ß-aminoethyl
x X X  .ether -N, N, N , N ,-tetraacetic acid EGTA .
2.4. Metabolic stimulation of endothelial cells
 .Bovine aortic endothelial cells line BKEz-7 were
 .cultivated in minimum essential medium MEM q
 .10% fetal calf serum FCS . For the micro-physio-
metric experiments the cells were seeded into 12 mm
diameter disposable polycarbonate cell capsules
 . 5Molecular Devices, Menlo Park, CA at 10
cellsrwell in MEMq10% FCS. The cultures were
incubated at 378C in a humidified atmosphere of 97%
airr3% CO for 48 h to attach to the membrane.2
The silicon micro-physiometer, a semiconductor-
based instrument, detects the extrusion of the acidic
metabolic products of glycolysis, respiration and ATP
hydrolysis, including lactic acid, CO , and protons2
w x28 . To measure the rate of acidification, the cultures
in the capsules were loaded into the chambers of the
 .micro-physiometer Cytosensor Molecular Devices
w xas described in detail elsewhere 28 . Briefly, the
chambers were perfused with the culture medium
lacking bicarbonate and with low buffering capacity
 .1 mM sodium phosphate , adjusted with sodium
chloride to obtain isotonic conditions. This medium
also contained alamethicin or its analogs as indicated
in the experiments. The flow rate in the micro-physi-
ometer was 50 mlrmin. Cells were perfused for 110 s
and the extracellular acidification rate being deter-
 .mined during each flow-off period 30 s from the
slope of a linear least-squares fit to the pH versus
 .time sec . After the acidification rate measurement,
the flow was restored for 110 s, during this time the
pH was re-equilibrated to a value close to that of the
perfusion medium. The entire flow onroff cycle time
 .was 150 s. Acidification rate data mVrs were math-
 .ematically normalized to a 100% metabolic rate
value at a time before any treatment. The
perfusionrhalt cycle and data processing was con-
trolled by a Macintosh PC interface. This allowed a
direct comparison of the acidification rate collected
from separate chambers with different initial rates.
Multiple determinations of the acidification rate were
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obtained and the data expressed as the average of at
least 3 determinations at a given time point and
shown as metabolic rate in percent.
The time dependency of the peptide induced
metabolic activity of the endothelial cells was deter-
mined by loading the cells into the chambers of the
micro-physiometer and determining the steady basal
rate. The cells were treated with a 14 mM peptide
solution for 3 min and then the chambers were per-
fused again with normal bicarbonate-free MEM and
the metabolic rate was monitored for an additional
60 min. To determine the dose dependency of the
Alam-P14 induced increase in the metabolic rate the
cells were exposed to different concentrations of
Alam-P14. The maximal response was calculated as
the percentage of the basal metabolic rate for each
chamber.
2.5. Dye release experiments
 .Large unilamellar vesicles LUVs in Tris-buffer
10 mM Tris, 154 mM NaCl, 0.1 mM EDTA, pHs
.7.4 containing 70 mM calcein for dye release experi-
ments were prepared from 1-palmitoyl-2-
oleoylphosphatidylcholine Avanti Polar Lipids, Al-
.  .abaster, USA POPC by repeated filtration using a
thermobarrel extruder Lipex Biomembranes, Van-
. w xcouver, Canada as described in 29 . Untrapped cal-
cein was removed from the vesicles by gel filtration
on a Sephadex G75 column. 10 ml LUV suspensions
were injected into a quartz cuvette containing mag-
netically stirred peptide solutions of different concen-
tration to a final volume of 2.6 ml. Calcein release
from the vesicles was monitored fluorometrically by
measuring the decrease in self-quenching excitation
.490 nm, emission 520 nm at room temperature on a
PerkinrElmer LS 50B spectrofluorimeter. The fluo-
rescence intensity corresponding to 100% leakage
was determined by the addition of 100 ml of 10%
Triton X-100 solution usually after 5 min of fluores-
 .cence recording. Percent leakage, F % after 1 min,
 . )  .was calculated by the equation 100 % Iy I ro
 .I y I where I is the intensity observed in the100% 0
peptide solution, and I and I are the fluores-o 100%
cence intensities measured in the absence of peptide
and in the presence of Triton X-100, respectively.
 .Peptide concentrations causing 50% dye efflux EC50
were estimated from dose-response curves.
2.6. Conformational in˝estigations
 .Small unilamellar vesicles SUVs for CD investi-
gations were prepared by suspending, vortexing and
sonicating POPC in 10 mM Tris buffer, pH 7.4 con-
w xtaining 154 mM NaF and 0.1 mM EDTA 29 . CD
spectra at 20 mM peptide concentration in the pres-
ence of 10 mM lipid were recorded on a J 720
 .spectrometer Jasco, Japan between 185 and 260 nm
at room temperature. Usually six scans were accumu-
lated for each sample and at least two independent
preparations for each type of sample were measured,
smoothed and averaged. Circular dichroism and dif-
ferential scattering of the SUVs were eliminated by
subtracting the lipid spectra of the corresponding
peptide-free suspensions. The helicity was deter-
w xmined from the mean residue elipticity Q at 222 nm
w x  .according to the relation Q sy30300 a q222
 . . w x2340 a amount of helix 30 . The error was 5%
helicity.
CD spectroscopically derived binding isotherms
were determined from the changes of the CD of
peptide solutions three different concentrations be-
y5 y6 .tween 5 P 10 molrl and 5 P 10 molrl after
adding different amounts of SUVs. Using for the CD
 . of the peptide the relations: FsQ 0 yQ Fy222 222
 .relative signal, Q 0 yellipticity at 222 nm in the222
absence of lipid, Q y measured ellipticity in222
.  .the presence of lipid and F s F C rC s‘ b p
 .F C rC r, where F is F of the completely bound‘ l p ‘
peptide, C the lipid concentration, C the total pep-l p
tide concentration, C the lipid-associated peptideb
concentration and rsC rC . F can be plottedb l
against C rC . From these equations and the massl p
conservation equation the binding isotherm can be
w xevaluated 31 . As an approximation peptide binding
at low r values can be described in terms of a
 . partition equilibrium K s rrC C yapp f f
.concentration of free peptide . We evaluated the ap-
 .parent binding constants K from the initial slopeapp
of the isotherms.
3. Results
 .Alamethicin Alam-P14 induced a dose-dependent
release of hemoglobin from human red blood cells
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Fig. 1. Lytic activity of Alam-P14: Dye release from POPC
 .LUVs black circles . The lipid concentration was 12 mM. The
EC was determined to be 1.8 mM. Hemoglobin release from50
 . 8human red blood cells open circles using 1.8=10 cellsrml.
The EC was found to be 30 mM. Values determined in repeat50
experiments differed by less than 5%.
 .Fig. 1 . The concentration of the half maximal effect
 .EC was determined to be 30 mM, corresponding50
to 1011 molecules per erythrocyte. Total hemolysis
was reached at 100 mM peptide concentration. No
hemolytic activity was found for the alamethicin
analogs with proline in positions 11 to 13 and 15 to
17 at peptide concentrations up to 200 mM. The
results indicated that alamethicin-induced hemoglobin
release from erythrocytes depends on the location of
proline at the native position 14.
Incubation of bovine adrenal chromaffin cells with
Alam-P14 in Ca2q-containing medium caused secre-
tion of catecholamines in a peptide concentration-de-
 .pendent mode Fig. 2 while no effect was observed
under Ca2q free conditions. A mild increase in cate-
cholamine secretion compared to the control was
found in the absence of Ca2q at 50 mM peptide
concentration. Even at this highest investigated con-
centration, alamethicin analogs with proline in differ-
ent positions showed no effect. Obviously, cate-
cholamine secretion from chromaffin cells was initi-
ated by the influx of Ca2q into the cells and the
ability of the peptides to promote this ion uptake was
strongly dependent on proline at position 14.
Incubation of bovine aortic endothelial cells for
3 min with 14 mM Alam-P14 induced after the appli-
cation of peptide a metabolic stimulation reaching
about 210% of the activity of control cells after about
 .15 min Fig. 3 . About 50 min after peptide treatment
the cells returned to the steady metabolic rate. The
stimulation of the metabolic rate was concentration
 .dependent up to about 20 mM alamethicin Fig. 4 .
At higher concentrations cell metabolism was inhib-
ited and the inhibition was not completely reversible
after washout of the drug, suggesting a toxic effect.
The six alamethicin analogs tested with proline at
 .position 12, 13, 15 Fig. 3 and 11, 16 and 17 did not
induce any stimulation of cell metabolism up to a
 .concentration of 100 mM data not shown . These
results indicated that the position 14 of proline in the
native sequence is an essential prerequisite for the
activity of alamethicin peptides with respect to
metabolic stimulation of endothelial cells.
Fig. 2. Concentration dependence of Alam-P14 induced cate-
cholamine secretion from bovine adrenal chromaffin cells. The
2q  .effect was investigated in Ca containing white columns and
2q  .Ca free black columns medium. The catecholamine secretion
is shown as percentage of total content. Data are means"S.D
from three experiments.
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Studying the permeabilizing activity of the alame-
thicin peptides on model membranes, the native
alamethicin was found to be most active in inducing
dye release from neutral, large unilamellar vesicles.
The EC at 12 mM POPC concentration was 1.8 mM50
 .Fig. 1 while all the analogs were completely inac-
tive at this concentration. Slightly enhanced dye re-
lease was observed with the analogs bearing proline
at more C-terminal positions at 80 mM concentration
 .data not shown leading to the suggestion that the
proline shift towards the N-terminus is more effective
in reducing activity than the shift to more C-terminal
positions.
The helicities of the peptides in the presence of
 .POPC vesicles varied significantly Table 2 . Com-
parison of the peptide affinities at POPC vesicles
revealed a reduction of the apparent binding constant
from about 4000 My1 for the native peptide, Alam-
P14 to about 800 My1 for Alam-P12, a representative
 .inactive analog Fig. 5 . The hydrophobicity of the
alamethicin peptides per residue, -H)s0.364 and
Fig. 3. Time dependence of metabolic rate changes of bovine
aortic endothelial cells induced by alamethicin peptides. Culti-
vated endothelial cells were loaded into a micro-physiometer and
treated with 14 mM peptide solutions for 3 min. Data shown are
 .representative of three separate experiments: Alam-P 14 v ;
 .  .  .Alam-P12 l ; Alam-P13 D ; Alam-P15 B .
Fig. 4. Dose dependence of Alam-P14 induced increase in
metabolic rate of bovine aortic endothelial cells. The endothelial
cells were exposed to different concentrations of alamethicin for
3 min, and the metabolic rate was monitored for an additional
60 min. The maximal responses were calculated as the percentage
of the basal metabolic rate. Data shown are the average of 3
similar experiments.
the hydrophobic moments -m) assuming an ideal
helix were calculated using the Eisenberg consensus
w x  .scale of hydrophobicity 32 Table 2 .
The results showed that any change in the position
of proline 14 drastically reduced the bilayer perme-
abilizing activity of alamethicin. The effects did not
Table 2
Helicity and hydrophobic moment of alamethicin peptides






Alam-Pro 16 42 0.088
Alam-Pro 17 38 0.132
 .Helicity a of alamethicin peptides in the presence of POPC
vesicles was determined at a peptide concentration of 25 mM and
lipid concentration of 10.4 mM; the hydrophobic moment -m)
w xwas calculated for an ideal helix according to Eisenberg 32 .
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 .  .Fig. 5. Binding isotherms of Alam-P14 v and Alam-P12 l
to POPC vesicles. The apparent binding constants derived from
the initial slope of the curves were 4000My1 and 800My1,
respectively.
correlate with peptide helicity but appeared depen-
dent on the peptide accumulation at the lipid matrix.
4. Discussion
 .This study shows that alamethicin F30 Alam-P14
exhibits activities on different mammalian cells in the
micromolar concentration range. The peptide induced
lysis of human red blood cells, stimulated cate-
cholamine secretion from bovine adrenal chromaffin
cells and increased the metabolic activity of bovine
aortic endothelial cells. Furthermore, it was found
that these activities strongly depend on the location
of proline at position 14 of the alamethicin chain.
The investigations of the action of Alam-P14 on
erythrocytes confirmed previous reports of the
hemolytic activity of alamethicin F50 bearing a glu-
w xtamine at position 18 5,8 . Interestingly, the peptide-
induced damage of the red blood cells disappeared
with any change in the position of proline 14. The
loss of activity correlated with modifications in the
permeability of model membranes exposed to alame-
thicin-peptides.
The lytic effect of alamethicin has been associated
w xwith its unique amphipathic bent-rod structure 5
which is mainly determined by the proline residue at
position 14. The lipophilic N-terminal alamethicin
helix has been suggested to be the most important
determinant for the membrane disturbing effect. It
may insert into the hydrophobic core of the mem-
brane and disturb hydrophobic lipid–lipid interac-
tions finally resulting in a release of membrane frag-
w xments 8 . However, the peptides investigated exhib-
ited quite different helicities in the membrane bound
state and there was no correlation between the amount
of helix and membrane activity. Therefore, we asso-
ciate the changes in the lytic activity of the alame-
thicin analogs first of all with changes in membrane
affinity and consequently a modification of the
amount of membrane associated peptides.
We have recently demonstrated, that the hemolytic
activity of amphipathic peptides and their permeabi-
lizing effect on neutral model membranes decreased
substantially on the reduction of peptide hydropho-
w xbicity and hydrophobic moment 25,29,33 . Reduced
binding was identified to be a decisive reason for the
effect. A correlation with peptide hydrophobicity was
also found comparing the lytic effects of alamethicin,
suzukacillin and trichotoxine towards erythrocytes,
w xleukocytes, mast cells and lymphocytes 7,8 . The
hydrophobicities of the alamethicin peptides with
proline at positions 11 to 17 are identical; however,
as shown for Alam-P12 compared to Alam-P14, the
apparent binding constant to neutral membranes was
substantially reduced. The low affinity of the analogs
might be related to changes in their hydrophobic
 .moment Table 2 . Changes in the orientation of the
N-terminal and C-terminal peptide regions caused by
the proline shift with respect to the lipid acyl chains
and polar membrane interface may additionally con-
tribute to the low membrane disturbing activity of the
proline substituted alamethicin analogs.
In bovine adrenal chromaffin cells, influx of Ca2q
into the cell is essential for triggering the secretion of
catecholamines. Our results demonstrate that alame-
thicin induces catecholamine release from chromaffin
cells in Ca2q containing media in a concentration-de-
pendent mode thus suggesting a peptide mediated
Ca2q entry into the cells. Furthermore, we confirmed
in a recent study that the alamethicin induces
voltage-dependent ion conductivity by channel for-
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w xmation in lipid bilayers 22 . Comparable properties
w xhave been described for trichosporin-Bs 9,10,34 . It
has been concluded that both trichosporin-Bs induced
macroscopic ion conductivity in lipid bilayers and
stimulation of catecholamine secretion from chromaf-
fin cells by the influx of external Ca2q are caused by
the formation of voltage-activated Ca2q-permeable
w xion channels 9,10 . Although alamethicin is less
active than trichosporin-Bs, it may be expected that
all these peptaibols induce catecholamine secretion
by a comparable mode of action. The barrel stave
model is widely accepted as explanation of the for-
mation of alamethicin ion channels by the parallel
transmembrane arrangement of peptide helices. Tak-
ing into consideration the diameters of the water
 . w x 2qfilled pores between 0.2 and 2 nm 22 , Ca ex-
change seems to be highly probable. Besides Ca2q
influx, alamethicin channel formation has also been
suggested to evoke Mn2q and Ni2q entry into chro-
w xmaffin cells 35 . Although our studies did not show a
convincing correlation between catecholamine secre-
tion and macroscopic conductance or single channel
forming properties of the proline substituted alame-
thicin analogs, the reduced size of channels and
w xdrastically reduced life times 22 could at least partly
explain the loss of catecholamine release stimulating
activity. Changes in the channel properties, such as
the reduced number of conductance levels and re-
duced life times, have also been suggested as being
responsible for a decrease of catecholamine secretion
induced by a trichosporin analog containing Aib in-
w x 14stead of Pro at position 14 9,20,34 and by des-Pro
w xtrichosporin 19 .
w xSimilar to trichosporin-B-VIa 20 , Alam-P14 at
high concentrations induced a Ca2q-independent ef-
flux of catecholamines, suggesting that the peptide
may damage the membrane of chromaffin cells. The
effect was not detectable for peptides with proline
shifted towards the N- and C-terminus thus correlat-
ing with the observations on erythrocytes and POPC
model membranes. The change in activity might be
interpreted in terms of low membrane binding caused
at least in part by changes in the hydrophobic mo-
ment as discussed above. The fact that the concentra-
tion of alamethicin necessary to induce membrane
damage was higher than the trichosporin B-VIa con-
w xcentration 9 implicated the role of peptide hy-
drophobicity which is much lower in Alam-P14 Hs
.  .0.364 than trichosporin B-VIa Hs0.409 . Finally,
channel formation at lower and membrane disruption
at higher alamethicin concentrations are in accor-
dance with the recently suggested principles for the
peptide-induced catecholamine secretion from chro-
w xmaffin cells 10 .
Furthermore, using a new technique in measuring
the extracellular acidification rate, it was shown that
alamethicin transiently stimulated the metabolic rate
of bovine aortic endothelial cells. The reversibility of
alamethicin induced metabolic activation is inter-
preted as a transient change in cell membrane in-
tegrity followed by a disturbance of the balance
between intracellular and extracellular ionic composi-
tion. To overcome this, ion pumps within the cell are
activated. These pumps are ATP dependent, resulting
in an enhanced cellular metabolism, and extrusion of
protons into the extracellular space thus causing an
w xincreased acidification rate 28 . Changes in the posi-
tion of proline 14 eliminated the stimulating activity
on endothelial cells. The findings correlate strongly
with the peptide induced permeabilization of the neu-
tral membrane of phosphatidylcholine vesicles and
largely with the macroscopic and single channel ex-
periments which imply that the native peptide in-
duced highest number, best resolved and most stable
w xconductance levels 22 . A reliable mechanistic inter-
pretation of the action of alamethicin on endothelial
cell membranes cannot be derived on the basis of
these results. Nevertheless, it seems clear that the
effect depends on proline at position 14 and on the
membrane-modifying properties of native alame-
thicin, which appear responsible for the exchange of
ions through the membrane.
In conclusion, the activity of Alam-P14 on differ-
ent mammalian cell systems was shown to depend
strongly on the peptide structure. The activities are
strongly related to proline at position 14 of the native
sequence. Ion exchange as a result of channel forma-
tion andror damage of the cell membrane may be
responsible for the effects. However, it is difficult to
arrive at an exact molecular interpretation of the
mechanism. Conformational changes induced by pro-
line substitution were found to change peptide affin-
ity and probably influence peptide flexibility and
orientation in the membrane. In addition, the architec-
ture of the different cell membranes and the different
transmembrane potentials of erythrocytes about
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. w x  . w xy9 mV 36 , endothelial cells about y10 mV 37
and chromaffin cells in the range of y60 to
. w xy80 mV 38 may modulate peptide membrane in-
teractions and are expected to influence the mode of
peptide induced membrane permeabilization.
Acknowledgements
The excellent assistance of R. Loose in the micro-
physiometry and H. Nikolenko in conformational in-
vestigations and dye release experiments is gratefully
acknowledged.
References
w x  .1 C.E. Meyer, F. Reusser, Experentia 23 1967 85–86.
w x2 W.-C. Jen, G.A. Jones, D. Brewer, V.O. Parkinson, A.
 .Taylor, J. Appl. Bacteriol. 63 1987 293–298.
w x3 S. Rebuffat, L. Contraux, M. Massias, C. Auvin-Guette, B.
 .Bodo, Int. J. Pept. Prot. Res. 41 1993 74–84.
w x4 M. El Hajji, S. Rebuffat, T. Le Doan, G. Klein, M. Sartre,
 .B. Bodo, Biochim. Biophys. Acta 978 1989 97–104.
w x5 G. Jung, N. Dubischar, G. Irmscher, W. Mayr, R.
 .Oekonomopolus, Chemiker Zeitung 101 1977 196–201.
w x  .6 H. Bruckner, H. Graf, M. Bokel, Experentia 40 1984¨
1189–1197.
w x7 W.G. Bessler, B. Ottenbreit, G. Irmscher, G. Jung, Biochim.
 .Biophys. Res. Commun. 87 1979 99–105.
w x  .8 G. Irmscher, G. Jung, Eur. J. Biochem. 80 1977 165–174.
w x9 Y. Nagaoka, A. Iida, T. Kambara, E. Tachikawa, K. Asami,
 .T. Fujita, Biol. Pharm. Bull. 18 1995 640–642.
w x10 E. Tachikawa, K. Nogimori, S. Takahashi, K. Mizuma, K.
Itoh, T. Kashimoto, Y. Nagaoka, A. Iida, T. Fujita, Biochim.
 .Biophys. Acta 1282 1996 140–148.
w x11 S.-I. Wada, A. Iida, K. Asami, E. Tachikawa, T. Fujita,
 .Biochim. Biophys. Acta 1325 1997 209–214.
w x  .12 Y. Takaishi, H. Terada, T. Fujita, Experentia 36 1980
550–552.
w x13 M. Okuda, A. Iida, S. Uesato, Y. Nagaoka, T. Fujita, Y.
 .Takaoshi, H. Terada, Biol. Pharm. Bull. 17 1994 482–485.
w x  .14 P. Mueller, O.D. Rudin, Nature 217 1968 713–719.
w x15 G. Menestrina, K.P. Voges, G. Jung, G. Boheim, J. Membr.
 .Biol. 93 1986 111–132.
w x  .16 G. Molle, H. Duclohier, G. Spach, FEBS Lett. 224 1987
208–212.
w x17 S. Rebuffat, S. Hlimi, Y. Prigent, C. Goulard, B. Bodo, J.
 .Chem. Soc. Perkin Trans. 1 1996 2021–2027.
w x18 H. Duclohier, G. Molle, G. Spach, Biochim. Biophys. Acta
 .987 1989 133–136.
w x19 A. Iida, S. Uesato, T. Shingu, Y. Nagaoka, Y. Kuroda, T.
 .Fujita, J. Chem. Soc. Perkin Trans. 1 1993 375–379.
w x20 Y. Nagaoka, A. Iida, T. Kambara, K. Asami, E. Tachikawa,
 .T. Fujita, Biochim. Biophys. Acta 1283 1996 31–36.
w x21 H. Duclohier, G. Molle, J.-Y. Dugast, G. Spach, Biophys. J.
 .63 1992 868–873.
w x22 C. Kaduk, H. Duclohier, M. Dathe, H. Wenschuh, M.
 .Beyermann, G. Molle, M. Bienert, Biophys. J. 72 1997
2151–2159.
w x23 H. Wenschuh, M. Beyermann, H. Haber, J.K. Seydel, E.
Krause, M. Bienert, L.A. Carpino, A. El Faham, F. Alberi-
 .cio, J. Org. Chem. 60 1995 405–410.
w x24 C. Kaduk, H. Wenschuh, M. Beyermann, K. Forner, L.A.
 .Carpino, M. Bienert, Lett. Pept. Sci. 2 1996 285–288.
w x25 M. Dathe, T. Wieprecht, H. Nikolenko, L. Handel, W.L.
Maloy, D.L. Mac Conald, M. Beyermann, M. Bienert, FEBS
 .Lett. 403 1997 208–212.
w x26 E. Tachikawa, S. Takahashi, K. Furumachi, T. Kashimoto,
A. Iida, A. Nagaoka, T. Fujita, Y. Takaishi, Mol. Pharma-
 .col. 40 1991 790–797.
w x  .27 H. Weil-Malherbe, A.D. Bone, Biochem. J. 51 1952 311–
318.
w x28 J.W. Parce, J.C. Owicki, K.M. Kersco, G.N. Sigal, H.G.
Wada, V.C. Mair, L.J. Bousse, K.L. Ross, B.L. Sikic, H.N.
 .Mc Connell, Science 246 1989 243–247.
w x29 M. Dathe, M. Schumann, T. Wieprecht, A. Winkler, M.¨
Beyermann, E. Krause, K. Matsuzaki, O. Murase, M. Bi-
 .enert, Biochemistry 35 1986 12612–12622.
w x30 Y.J. Chen, J.T. Yang, H.M. Martinez, Biochemistry 11
 .1972 4120–4131.
w x31 G. Schwarz, G. Beschiaschvili, Biochim. Biophys. Acta 979
 .1989 82–90.
w x  .32 D. Eisenberg, Ann. Rev. Biochem. 53 1994 595–623.
w x33 T. Wieprecht, M. Dathe, M. Beyermann, E. Krause, W.L.
 .Maloy, D. Mac Donald, M. Bienert, Biochemistry 36 1997
6124–6132.
w x34 Y. Nagaoka, A. Iida, T. Kambara, E. Tachikawa, T. Fujita,
 .Chem. Pharm. Bull. 43 1995 1119–1124.
w x35 R.I. Fonteriz, M.G. Lopez, J. Garcia-Sancho, A.G. Garcia,
 .FEBS Lett. 283 1991 89–92.
w x36 T.J. Rink, S.B. Hladky in: J.C. Ellory and J.D. Young
 .Eds. , Red Cell Membranes- A Methodological Approach,
Academic Press, London, 1982, pp. 321–334.
w x37 S. Mendes, I. Windeck, K.-H. Lichtnow, E. Teuscher, Phar-
 .mazie 47 1992 930–933.
w x38 M.G. Lopez, A.R. Artalejo, A.G. Garcia, E. Neher, E.J.
 .Garcia-Sancho, J. Physiol. 482 1995 15–27.
